After 20 years of research, Dr. Linda Dwoskin and her team may be close to developing the first-ever medication to treat methamphetamine addiction. She and colleagues at the Universities of Kentucky and Arkansas have created a molecule that blocks methamphetamine’s addictive effects and studies have completed preclinical testing without raising any red flags for undesirable side effects. Read more about efforts to develop medication to treat methamphetamine addiction.

 

Study Details